Patents by Inventor Janet Rossant

Janet Rossant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050191742
    Abstract: Stable pluripotent trophoblast stem (TS) cell lines and uses of the cell lines are described. The cell lines comprise cells that (i) are capable of indefinite proliferation in vitro in an undifferentiated state; and (ii) are capable of differentiation into cells of the trophoblast lineage in vivo.
    Type: Application
    Filed: August 6, 2003
    Publication date: September 1, 2005
    Applicant: Mount Sinai Hospital
    Inventors: Janet Rossant, Satoshi Tanaka, Tilo Kunath
  • Patent number: 6630349
    Abstract: Stable pluripotent trophoblast stem (TS) cell lines and uses of the cell lines are described. The cell lines comprise cells that (i) are capable of indefinite proliferation in vitro in an undifferentiated state, and (ii) are capable of differentiation into cells of the trophoblast lineage in vivo.
    Type: Grant
    Filed: March 7, 2001
    Date of Patent: October 7, 2003
    Assignee: Mount Sinai Hospital
    Inventors: Janet Rossant, Satoshi Tanaka, Tilo Kunath
  • Patent number: 5998187
    Abstract: Novel receptor tyrosine kinase protein and isoforms thereof which are expressed in cells of the endothelial lineage, and DNA segments encoding the novel protein and isoforms thereof are disclosed. Methods for identifying ligands which are capable of binding to the receptor protein and methods for screening for agonist or antagonist substances of the interaction of the protein and a ligand are also disclosed.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: December 7, 1999
    Assignee: Mount Sinai Hospital Corporation
    Inventors: Martin L. Breitman, Janet Rossant, Daniel J. Dumont, Terry P. Yamaguchi, Jo-Ann Breitman
  • Patent number: 5681714
    Abstract: Novel receptor tyrosine kinase protein and isoforms thereof which are expressed in cells of the endothelial lineage, and DNA segments encoding the novel protein and isoforms thereof are disclosed. Methods for identifying ligands which are capable of binding to the receptor protein and methods for screening for agonist or antagonist substances of the interaction of the protein and a ligand are also disclosed.
    Type: Grant
    Filed: July 20, 1994
    Date of Patent: October 28, 1997
    Assignee: Mount Sinai Hospital Corporation
    Inventors: Martin L. Breitman, deceased, Janet Rossant, Daniel J. Dumont, Terry P. Yamaguchi